Artia Global Partners as of March 31, 2025
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 32 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 29.2 | $116M | 140k | 825.91 | |
| Soleno Therapeutics (SLNO) | 13.3 | $53M | 735k | 71.45 | |
| Verona Pharma Sponsored Ads (VRNA) | 8.7 | $34M | 539k | 63.49 | |
| Intra Cellular Therapies (ITCI) | 7.3 | $29M | 220k | 131.92 | |
| Insmed Com Par $.01 (INSM) | 6.1 | $24M | 318k | 76.29 | |
| Merus N V (MRUS) | 4.5 | $18M | 425k | 42.09 | |
| Protagonist Therapeutics (PTGX) | 4.1 | $16M | 334k | 48.36 | |
| Arcellx Common Stock (ACLX) | 3.8 | $15M | 229k | 65.60 | |
| Astrazeneca Sponsored Adr | 3.5 | $14M | 191k | 73.50 | |
| Boston Scientific Corporation (BSX) | 3.3 | $13M | 130k | 100.88 | |
| Quest Diagnostics Incorporated (DGX) | 2.4 | $9.6M | 57k | 169.20 | |
| Alnylam Pharmaceuticals (ALNY) | 2.0 | $7.7M | 29k | 270.02 | |
| Argenx Se Sponsored Adr (ARGX) | 1.7 | $6.7M | 11k | 591.87 | |
| Nuvalent Inc-a (NUVL) | 1.6 | $6.4M | 91k | 70.92 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $5.5M | 172k | 32.15 | |
| Revolution Medicines (RVMD) | 0.9 | $3.7M | 104k | 35.36 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $2.6M | 50k | 52.97 | |
| Springworks Therapeutics (SWTX) | 0.6 | $2.4M | 54k | 44.13 | |
| Viking Therapeutics (VKTX) | 0.6 | $2.2M | 90k | 24.15 | |
| Miragen Therapeutics (VRDN) | 0.5 | $2.2M | 160k | 13.48 | |
| Tg Therapeutics (TGTX) | 0.5 | $2.1M | 55k | 39.43 | |
| Intuitive Surgical Com New (ISRG) | 0.4 | $1.7M | 3.5k | 495.27 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.4 | $1.7M | 317k | 5.42 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $1.6M | 15k | 110.60 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $1.5M | 5.0k | 308.27 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $1.3M | 40k | 33.55 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $1.2M | 7.4k | 155.86 | |
| Janux Therapeutics (JANX) | 0.3 | $1.0M | 38k | 27.00 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $948k | 421k | 2.25 | |
| Travere Therapeutics (TVTX) | 0.1 | $554k | 31k | 17.92 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $507k | 35k | 14.38 | |
| Oruka Therapeutics (ORKA) | 0.0 | $76k | 7.4k | 10.26 |
